Log in

Relevant bibliographies by topics / Endocrine aspects / Journal articles

Journal articles on the topic 'Endocrine aspects'

To see the other types of publications on this topic, follow the link: Endocrine aspects.

Author: Grafiati

Published: 4 June 2021

Last updated: 30 July 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Endocrine aspects.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Akopova, R. A., and T. V. Kokoreva. "ENDOCRINE ASPECTS OF MALE INFERTILITY." Bulletin "Biomedicine and sociology" 3, no. 4 (December 30, 2018): 17–19. http://dx.doi.org/10.26787/nydha-2618-8783-2018-3-4-17-19.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Fountoulakis, Stelios, and Agathocles Tsatsoulis. "Molecular genetic aspects and pathophysiology of endocrine hypertension." HORMONES 5, no. 2 (April 15, 2006): 90–106. http://dx.doi.org/10.14310/horm.2002.11173.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

KALTENBACH, JANE C. "Endocrine Aspects of Homeostasis." American Zoologist 28, no. 2 (May 1988): 761–73. http://dx.doi.org/10.1093/icb/28.2.761.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Shalet, SM. "Endocrine aspects of cancer." British Journal of Cancer 70, no. 3 (September 1994): 569. http://dx.doi.org/10.1038/bjc.1994.347.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Glass, Allan R. "Endocrine Aspects of Obesity." Medical Clinics of North America 73, no. 1 (January 1989): 139–60. http://dx.doi.org/10.1016/s0025-7125(16)30696-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Proietto, Joseph. "Endocrine aspects of obesity." Molecular and Cellular Endocrinology 316, no. 2 (March 2010): 103. http://dx.doi.org/10.1016/j.mce.2009.12.004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Sica, G. "Pathophysiologic and Endocrine Aspects." Journal of International Medical Research 18, no. 1_suppl (January 1990): 8–10. http://dx.doi.org/10.1177/03000605900180s103.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Drent, M. "Endocrine aspects of obesity." Netherlands Journal of Medicine 47, no. 3 (September 1995): 127–36. http://dx.doi.org/10.1016/0300-2977(95)00008-b.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Vagenakis, A. G. "Endocrine aspects of menopause." Clinical Rheumatology 8, S2 (June 1989): 48–51. http://dx.doi.org/10.1007/bf02207233.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Rapaport, Robert. "Endocrine Aspects of Aging." Endocrinology and Metabolism Clinics of North America 52, no. 2 (June 2023): xiii. http://dx.doi.org/10.1016/j.ecl.2023.02.007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Murialdo, G., and G. Tamagno. "Endocrine aspects of neurosarcoidosis." Journal of Endocrinological Investigation 25, no. 7 (July 2002): 650–62. http://dx.doi.org/10.1007/bf03345093.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Aboimova, E. V., and G. A. Azamatova. "Endocrine ophthalmopathy: historical aspects." Modern technologies in ophtalmology, no. 5 (October 6, 2023): 7–10. http://dx.doi.org/10.25276/2312-4911-2023-5-7-10.

Full text

Abstract:

The article presents the history of the development of the treatment of endocrine ophthalmopathy from the first mention of disparate symptoms of the disease in 110 ad to the principles of therapy accepted today. Caleb parry was the first to describe 8 such patients, but his work did not attract the attention of the medical community. In 1835, the Englishman robert graves, in his «clinical lectures», described 3 patients with a disease that was later named after him. a little later, the clinical cases of 4 patients were presented by Karl Basedow, who also suggested that the body was «poisoned» with a toxin as a result of the disease. treatment of toxic goiter with exophthalmos remained symptomatic for a long time. Surgery was resorted to as a «treatment of despair» in neglected patients, which led to high mortality after operations. attempts at surgical intervention on the eye sockets were also ineffective. But at the beginning of the 20th century, several discoveries were made that significantly influenced the effectiveness of treatment. Since 1902, x-ray and then radioisotope irradiation of the thyroid gland entered clinical practice, which led to the recovery of 2/3 of patients. developing after radiotherapy and surgery, hypothyroidism began to stop thyroxine, synthesized in 1926 by charles harrington. the discovery of the thyrostatic properties of thiourea by Edwin astwood in 1946 made it possible to significantly improve the effectiveness of the treatment of patients with hyperthyroidism. the modern era in the treatment of endocrine ophthalmopathy began in the 90s of the last century, when pulse therapy with high doses of glucocorticoid hormones was first proposed. therapy with high-dose corticosteroids remains the «gold standard» for the treatment of endocrine ophthalmopathy to this day. Keywords: endocrine ophthalmopathy, exophthalmos, goiter, thyroid gland, study history

APA, Harvard, Vancouver, ISO, and other styles

13

Sonino, N., J. Guidi, and GA Fava. "Psychological aspects of endocrine disease." Journal of the Royal College of Physicians of Edinburgh 45, no. 1 (2015): 55–59. http://dx.doi.org/10.4997/jrcpe.2015.113.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Ilić, Saša, Draško Gostiljac, Vesna Dimitrijević-Srećković, and Srđan Popović. "Endocrine aspects of Crohn's disease." Medicinski glasnik Specijalne bolnice za bolesti štitaste žlezde i bolesti metabolizma 24, no. 74 (2019): 7–18. http://dx.doi.org/10.5937/medgla1973007i.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Sahin, Ozlem G., Elçin Kartal, and Nusret Taheri. "Meibomian Gland Dysfunction: Endocrine Aspects." ISRN Ophthalmology 2011 (October 20, 2011): 1–6. http://dx.doi.org/10.5402/2011/465198.

Full text

Abstract:

Purpose. To compare the hormone levels of patients with seborrheic meibomian gland dysfunction with controls. Procedures. This is a retrospective case-control study involving 50 patients and 50 controls. Blood workup for hormones was studied in both groups by using macroELISA (enzyme-linked immunosorbent assay). Statistical evaluation was done by using SPSS 15.0 independent samples -test. Results. There were statistically significant differences of serum testosterone and dehydroepiandrosterone sulphate levels between patients and controls (P = 0.000). Female gender showed statistically significant differences of serum thyroid-stimulating hormone and prolactin levels between patients and controls (P = 0.014 and P = 0.043), in addition to serum testosterone and dehydroepiandrosterone sulphate levels (P = 0.000 and P = 0.001). However, male gender showed statistically significant differences of only serum testosterone and dehydroepiandrosterone sulphate levels between patients and controls. (P = 0.003 and P = 0.003 resp.). Conclusions. Increased serum levels of testosterone and dehydroepiandrosterone sulphate in both genders should be considered as diagnostic markers for seborrheic meibomian gland dysfunction.

APA, Harvard, Vancouver, ISO, and other styles

16

Yoo, Hyung Joon. "Antiaging Efforts in Endocrine Aspects." Journal of the Korean Medical Association 50, no. 3 (2007): 234. http://dx.doi.org/10.5124/jkma.2007.50.3.234.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Wu, F. C. W. "Endocrine aspects of anabolic steroids." Clinical Chemistry 43, no. 7 (July 1, 1997): 1289–92. http://dx.doi.org/10.1093/clinchem/43.7.1289.

Full text

Abstract:

Abstract Understanding of the mechanism of androgen action has been enhanced by advances in knowledge on the molecular basis of activation of the androgen receptor and the importance of tissue conversion of circulating testosterone to dihydrotestosterone and estradiol. New evidence supports the view that supraphysiological doses of anabolic steroids do have a definite, positive effect on muscle size and muscle strength. However, the nature of the anabolic action of androgens on muscle is currently unclear and may involve mechanisms independent of the androgen receptor. The dose–response relationships of anabolic actions vs the potentially serious risks to health of androgenic-anabolic steroids (AAS) use are still unresolved. Most of the adverse effects of AAS are reversible but some are permanent, particularly in women and children. The reported incidence of acute life-threatening events associated with AAS abuse is low, but the actual risk may be underrecognized or underreported; the exact incidence is unknown. The long-term consequences and disease risks of AAS to the sports competitor remain to be properly evaluated.

APA, Harvard, Vancouver, ISO, and other styles

18

Lizarazo, Adriana Herrera, Michelle McLoughlin, and Maria G. Vogiatzi. "Endocrine aspects of Klinefelter syndrome." Current Opinion in Endocrinology & Diabetes and Obesity 26, no. 1 (February 2019): 60–65. http://dx.doi.org/10.1097/med.0000000000000454.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Higgins, NiallO'. "ENDOCRINE ASPECTS OF BREAST CANCER." ANZ Journal of Surgery 57, no. 10 (October 1987): 697–701. http://dx.doi.org/10.1111/j.1445-2197.1987.tb01246.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Franks, Stephen. "Endocrine Aspects of Menstrual Disorders." Medicine 29, no. 11 (November 2001): 34–37. http://dx.doi.org/10.1383/medc.29.11.34.28432.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Currie, Gemma, David M. Carty, John M. Connell, and Marie Freel. "Endocrine aspects of pre-eclampsia." Cardiovascular Endocrinology 4, no. 1 (March 2015): 1–10. http://dx.doi.org/10.1097/xce.0000000000000039.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Sonino, Nicoletta, and Giovanni A. Fava. "Psychological aspects of endocrine disease." Clinical Endocrinology 49, no. 1 (July 1998): 1–7. http://dx.doi.org/10.1046/j.1365-2265.1998.00528.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Pantelakis, Chairmen: S., and CR Rodda. "Endocrine aspects of thalassaemia major." Acta Paediatrica 83, s406 (December 1994): 105–6. http://dx.doi.org/10.1111/j.1651-2227.1994.tb13435.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Bravo, Emmanuel L. "Clinical Aspects of Endocrine Hypertension." Medical Clinics of North America 71, no. 5 (September 1987): 907–20. http://dx.doi.org/10.1016/s0025-7125(16)30816-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Hofbauer, Lorenz C., Tilman D. Rachner, Robert E. Coleman, and Franz Jakob. "Endocrine aspects of bone metastases." Lancet Diabetes & Endocrinology 2, no. 6 (June 2014): 500–512. http://dx.doi.org/10.1016/s2213-8587(13)70203-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Müller, B. "Endocrine aspects of critical illness." Annales d'Endocrinologie 68, no. 4 (September 2007): 290–98. http://dx.doi.org/10.1016/j.ando.2007.06.006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Shalet, S. M. "Endocrine Aspects of Acute Illness." Postgraduate Medical Journal 61, no. 722 (December 1, 1985): 1099. http://dx.doi.org/10.1136/pgmj.61.722.1099.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Harrison, Timothy S. "Endocrine aspects of acute illness." American Journal of Surgery 151, no. 5 (May 1986): 639. http://dx.doi.org/10.1016/0002-9610(86)90578-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Pervanidou, Panagiota, Evangelia Charmandari, and George P. Chrousos. "Endocrine Aspects of Childhood Obesity." Current Pediatrics Reports 1, no. 2 (February 2, 2013): 109–17. http://dx.doi.org/10.1007/s40124-013-0011-y.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Boehm, B. O., and N. R. Farid. "Molecular aspects of endocrine autoimmunity." Clinical Investigator 71, no. 1 (January 1993): 79–81. http://dx.doi.org/10.1007/bf00210975.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Beall, G. N. "Immunologic aspects of endocrine diseases." JAMA: The Journal of the American Medical Association 258, no. 20 (November 27, 1987): 2952–56. http://dx.doi.org/10.1001/jama.258.20.2952.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Baker, James R. "Immunologic Aspects of Endocrine Diseases." JAMA: The Journal of the American Medical Association 268, no. 20 (November 25, 1992): 2899. http://dx.doi.org/10.1001/jama.1992.03490200151017.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

LIECHTY, R. DALE. "Endocrine Aspects of Acute Illness." Archives of Surgery 120, no. 11 (November 1, 1985): 1327. http://dx.doi.org/10.1001/archsurg.1985.01390350103032.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Klowden, Marc J. "Endocrine aspects of mosquito reproduction." Archives of Insect Biochemistry and Physiology 35, no. 4 (1997): 491–512. http://dx.doi.org/10.1002/(sici)1520-6327(1997)35:4<491::aid-arch10>3.0.co;2-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Baker, J. R. "Immunologic aspects of endocrine diseases." JAMA: The Journal of the American Medical Association 268, no. 20 (November 25, 1992): 2899–903. http://dx.doi.org/10.1001/jama.268.20.2899.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Beall, Gildon N. "Immunologic Aspects of Endocrine Diseases." JAMA: The Journal of the American Medical Association 258, no. 20 (November 27, 1987): 2952. http://dx.doi.org/10.1001/jama.1987.03400200158019.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Harrison, Barney. "Endocrine Surgical Aspects of Multiple Endocrine Neoplasia Syndromes in Children." Hormone Research in Paediatrics 68, no. 5 (2007): 105–6. http://dx.doi.org/10.1159/000110590.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

KANNO, Jun. "Endocrine Disrupting Chemicals : Their Biological Aspects." Journal of Synthetic Organic Chemistry, Japan 57, no. 1 (1999): 35–39. http://dx.doi.org/10.5059/yukigoseikyokaishi.57.35.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Larsson, Jörgen. "Endocrine aspects of exocrine pancreatic cancer." International Journal of Pancreatology 12, no. 3 (December 1992): 323. http://dx.doi.org/10.1007/bf02924373.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Nappi, Francesca, Luigi Barrea, Carolina Di Somma, Maria Savanelli, Giovanna Muscogiuri, Francesco Orio, and Silvia Savastano. "Endocrine Aspects of Environmental “Obesogen” Pollutants." International Journal of Environmental Research and Public Health 13, no. 8 (July 28, 2016): 765. http://dx.doi.org/10.3390/ijerph13080765.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Steller, Michael A., Donald P. Goldstein, and Ross S. Berkowitz. "Endocrine Aspects of Gestational Trophoblastic Disease." Endocrinologist 3, no. 2 (March 1993): 136–48. http://dx.doi.org/10.1097/00019616-199303000-00009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Josso, N. "The undervirilized male child: endocrine aspects." BJU International 93, s3 (May 2004): 3–5. http://dx.doi.org/10.1111/j.1464-410x.2004.04702.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Wierman, Margaret E., Rossella E. Nappi, Nancy Avis, Susan R. Davis, Ferdinand Labrie, Willam Rosner, and Jan L. Shifren. "Endocrine Aspects of Women's Sexual Function." Journal of Sexual Medicine 7, no. 1 (January 2010): 561–85. http://dx.doi.org/10.1111/j.1743-6109.2009.01629.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Buvat, Jacques, Mario Maggi, Louis Gooren, Andre T. Guay, Joel Kaufman, Abraham Morgentaler, Claude Schulman, et al. "Endocrine Aspects of Male Sexual Dysfunctions." Journal of Sexual Medicine 7, no. 4 (April 2010): 1627–56. http://dx.doi.org/10.1111/j.1743-6109.2010.01780.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Pichugova, S. V., J. G. Lagereva, I. V. Rybina, S. V. Belyaeva, L. G. Tulakina, and Ya B. Beykin. "Immuno-Endocrine Aspects of Male Infertility." Journal of Ural Medical Academic Science 14, no. 2 (2016): 102–25. http://dx.doi.org/10.22138/2500-0918-2016-14-2-102-125.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Barzon, Luisa, Marco Boscaro, and Giorgio Palù. "Endocrine Aspects of Cancer Gene Therapy." Endocrine Reviews 25, no. 1 (February 1, 2004): 1–44. http://dx.doi.org/10.1210/er.2002-0035.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Davis, Susan R., André T. Guay, Jan L. Shifren, and Norman A. Mazer. "Endocrine Aspects of Female Sexual Dysfunction." Journal of Sexual Medicine 1, no. 1 (July 2004): 82–86. http://dx.doi.org/10.1111/j.1743-6109.2004.10112.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Attal, Pierre, and Philippe Chanson. "Endocrine Aspects of Obstructive Sleep Apnea." Journal of Clinical Endocrinology & Metabolism 95, no. 2 (February 1, 2010): 483–95. http://dx.doi.org/10.1210/jc.2009-1912.

Full text

Abstract:

Abstract Context: Some endocrine and metabolic disorders are associated with a high frequency of obstructive sleep apnea (OSA), and treatment of the underlying endocrine disorder can improve and occasionally cure OSA. On the other hand, epidemiological and interventional studies suggest that OSA increases the cardiovascular risk, and a link between OSA and glucose metabolism has been suggested, via reduced sleep duration and/or quality. Evidence Acquisition: We reviewed the medical literature for key articles through June 2009. Evidence Synthesis: Some endocrine and metabolic conditions (obesity, acromegaly, hypothyroidism, polycystic ovary disease, etc.) can be associated with OSA. The pathophysiological mechanisms of OSA in these cases are reviewed. In rare instances, OSA may be improved or even cured by treatment of underlying endocrine disorders: this is the case of hypothyroidism and acromegaly, situations in which OSA is mainly related to upper airways narrowing due to reversible thickening of the pharyngeal walls. However, when irreversible skeletal defects and/or obesity are present, OSA may persist despite treatment of endocrine disorders and may thus require complementary therapy. This is also frequently the case in patients with obesity, even after substantial weight reduction. Conclusions: Given the potential neurocognitive consequences and increased cardiovascular risk associated with OSA, specific therapy such as continuous positive airway pressure is recommended if OSA persists despite effective treatment of its potential endocrine and metabolic causes. “Apropos of sleep, that sinister adventure of all our nights, we might say that men go to bed daily with an audacity that would be incomprehensible if we did not know that it is the result of ignorance of the danger.” Charles Baudelaire, in “Fusées, IX”

APA, Harvard, Vancouver, ISO, and other styles

49

Garrigues, Ph. "Endocrine disruptors: Analytical and toxicological aspects." Analusis 28, no. 9 (November 2000): 761–62. http://dx.doi.org/10.1051/analusis:2000280761.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Petersén, Åsa, and Maria Björkqvist. "Hypothalamic-endocrine aspects in Huntington's disease." European Journal of Neuroscience 24, no. 4 (August 2006): 961–67. http://dx.doi.org/10.1111/j.1460-9568.2006.04985.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!